de Abajo Francisco J, Montero Dolores, Madurga Mariano, García Rodríguez Luis A
Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines Agency, Madrid, Spain.
Br J Clin Pharmacol. 2004 Jul;58(1):71-80. doi: 10.1111/j.1365-2125.2004.02133.x.
To provide quantitative information about the absolute and relative risks of acute and clinically relevant drug-induced liver injury.
We performed a population-based case-control study using the UK-based General Practice Research Database as the source of information. A total of 1,636,792 persons subjects aged 5-75 years old registered in the database from 1 January, 1994 to 31 December, 1999 were followed-up for a total of 5,404,705 person-years. Cases were identified by an exhaustive computer search, then reviewed manually and finally validated against the clinical records. Only idiopathic cases serious enough to be referred to hospital or a consultant were selected. A total of 5000 controls were randomly sampled from the person-time of study cohort. Current users were defined if a prescription ended within 15 days of the index date, and nonusers if there was no prescription before the index date.
One hundred and twenty-eight patients were considered as valid cases, being the crude incidence rate of 2.4 (95% confidence interval: 2.0, 2.8) per 100 000 person-years. The strongest associations were found with chlorpromazine (adjusted odds ratio (AOR); 95% CI = 416; 45, 3840), amoxicillin/clavulanic acid (AOR = 94.8; 27.8, 323), flucloxacillin (AOR = 17.7; 4.4, 71.0), macrolides (AOR = 6.9; 2.3, 21.0), tetracyclines (AOR = 6.2; 2.4, 15.8); metoclopramide (AOR = 6.2; 1.8, 21.3); chlorpheniramine (AOR = 9.6; 1.9, 49.7); betahistine (AOR = 15.3; 2.9, 80.7); sulphasalazine (AOR = 25.5; 6.0, 109); azathioprine (AOR = 10.5; 1.4, 76.4), diclofenac (AOR = 4.1; 1.9, 8.8) and antiepileptics (AOR = 5.1; 1.9, 13.7). A dose-effect was apparent for diclofenac, amoxicillin/clavulanic acid and flucloxacillin. The combination of two or more hepatotoxic drugs increased the risk by a factor of 6. The highest crude incidence rates were found for chlorpromazine, azathioprine, and sulfasalazine (about 1 per 1000 users).
Idiopathic, acute and clinically relevant liver injury, which has the use of drugs as the most probable aetiology, is a rare event in the general population. The relative risks of 40 drugs/therapeutic classes are provided, along with the crude incidence rates for 15 of them where a statistical association was found.
提供关于急性和临床相关药物性肝损伤的绝对风险和相对风险的定量信息。
我们进行了一项基于人群的病例对照研究,使用英国全科医学研究数据库作为信息来源。对1994年1月1日至1999年12月31日在该数据库中注册的1,636,792名年龄在5至75岁的受试者进行了总计5,404,705人年的随访。通过详尽的计算机搜索识别病例,然后人工复查,最后对照临床记录进行验证。仅选择病情严重到足以转诊至医院或咨询专家的特发性病例。从研究队列的人时中随机抽取5000名对照。如果处方在索引日期后15天内结束,则定义为当前使用者;如果在索引日期前没有处方,则定义为非使用者。
128名患者被视为有效病例,粗发病率为每10万人年2.4例(95%置信区间:2.0,2.8)。发现与氯丙嗪(调整比值比(AOR);95%CI = 416;45,3840)、阿莫西林/克拉维酸(AOR = 94.8;27.8,323)、氟氯西林(AOR = 17.7;4.4,71.0)、大环内酯类(AOR = 6.9;2.3,21.0)、四环素类(AOR = 6.2;2.4,15.8);甲氧氯普胺(AOR = 6.2;1.8,21.3);氯苯那敏(AOR = 9.6;1.9,49.7);倍他司汀(AOR = 15.3;2.9,80.7);柳氮磺胺吡啶(AOR = 25.5;6.0,109);硫唑嘌呤(AOR = 10.5;1.4,76.4)、双氯芬酸(AOR = 4.1;1.9,8.8)和抗癫痫药(AOR = 5.1;1.9,13.7)的关联最强。双氯芬酸、阿莫西林/克拉维酸和氟氯西林存在剂量效应。两种或更多种肝毒性药物联合使用会使风险增加6倍。氯丙嗪、硫唑嘌呤和柳氮磺胺吡啶的粗发病率最高(每1000名使用者中约1例)。
以药物使用为最可能病因的特发性、急性和临床相关肝损伤在普通人群中是罕见事件。提供了40种药物/治疗类别的相对风险,以及其中15种发现有统计学关联的药物的粗发病率。